ArticleJAMA neurology2021

Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab.

Livnat Brill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.